Work

Pulse-continuous dose erlotinib as initial targeted therapy for patients with EGFR-mutant lung cancers with untreated brain metastases.

Year: 2017

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2017.35.15_suppl.9039

Authors: Mark G. Kris, Kathryn Cecilia Arbour, Gregory J. Riely, Ai Ni, Kathryn Beal, Mariza Daras, Sara A. Hayes, Robert J. Young, Christopher R Rodriguez, William Pao, Helena Alexandra Yu

Institutions: Memorial Sloan Kettering Cancer Center, F. Hoffmann-La Roche AG

Language: English

Topic: Brain Metastases and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2890725516

Cites:

Cited by: 1

Related to: 10